PolyNovo Limited Stock price

Equities

PNV

AU000000PNV0

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. 01:10:10 2024-03-28 am EDT 5-day change 1st Jan Change
2.19 AUD +2.34% Intraday chart for PolyNovo Limited -0.45% +32.33%
Sales 2024 * 103M 66.86M Sales 2025 * 133M 86.81M Capitalization 1.51B 984M
Net income 2024 * 3M 1.95M Net income 2025 * 13M 8.47M EV / Sales 2024 * 14.3 x
Net cash position 2024 * 42.64M 27.76M Net cash position 2025 * 37.06M 24.13M EV / Sales 2025 * 11.1 x
P/E ratio 2024 *
363 x
P/E ratio 2025 *
112 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.66%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.34%
1 week-0.45%
Current month-3.95%
1 month+2.82%
3 months+31.14%
6 months+65.91%
Current year+32.33%
More quotes
1 week
2.06
Extreme 2.06
2.22
1 month
2.06
Extreme 2.06
2.52
Current year
1.48
Extreme 1.475
2.52
1 year
1.10
Extreme 1.095
2.52
3 years
0.84
Extreme 0.835
3.19
5 years
0.75
Extreme 0.745
4.08
10 years
0.07
Extreme 0.07
4.08
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22-07-28
Director of Finance/CFO - 18-12-11
Chief Tech/Sci/R&D Officer - 23-05-21
Members of the board TitleAgeSince
Chairman 70 14-02-27
Director/Board Member 68 10-02-17
Chief Tech/Sci/R&D Officer - 12-08-05
More insiders
Date Price Change Volume
24-03-28 2.19 +2.34% 1,108,859
24-03-27 2.14 +1.90% 1,793,957
24-03-26 2.1 -0.94% 6,338,523
24-03-25 2.12 -0.47% 2,646,839
24-03-22 2.13 -3.18% 1,118,356

Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT

More quotes
PolyNovo Limited is an Australia-based company, which is engaged in the development of medical devices for various medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM product is designed to help surgeons treat traumatic wounds. NovoSorb BTM may be used to temporarily close the wound and aid the body in generating new tissue. It is indicated for full or deep partial-thickness burns, surgical and reconstructive wounds and traumatic wounds. BTM is applied to a wound once the unhealthy or dead tissue has been surgically removed. NovoSorb is a medical-grade polymers that can be expressed in a range of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
2.19 AUD
Average target price
2.113 AUD
Spread / Average Target
-3.50%
Consensus
  1. Stock
  2. Equities
  3. Stock PolyNovo Limited - Australian S.E.